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Abstract
Background: Eph kinases are the largest family of cell surface receptor tyrosine kinases. The ligands of Ephs,
ephrins (EFNs), are also cell surface molecules. Ephs interact with EFNs transmitting signals in both directions, i.e.,
from Ephs to EFNs and from EFNs to Ephs. EFNB1 is known to be able to co-stimulate T cells in vitro and to
modulate thymocyte development in a model of foetal thymus organ culture. To further understand the role of
EFNB1 in T cell immunity, we generated T-cell-specific EFNB1 gene knockout mice to assess T cell development
and function in these mice.
Results: The mice were of normal size and cellularity in the thymus and spleen and had normal T cell
subpopulations in these organs. The bone marrow progenitors from KO mice and WT control mice repopulated
host spleen T cell pool to similar extents. The activation and proliferation of KO T cells was comparable to that of
control mice. Naïve KO CD4 cells showed an ability to differentiate into Th1, Th2, Th17 and Treg cells similar to
control CD4 cells.
Conclusions: Our results suggest that the function of EFNB1 in the T cell compartment could be compensated by
other members of the EFN family, and that such redundancy safeguards the pivotal roles of EFNB1 in T cell
development and function.
Background
Eph kinases are the largest family of cell surface recep-
tor tyrosine kinases and can be divided into A and B
subfamilies according to their sequence homology. The
ligands of Ephs, ephrins (EFNs), are also cell surface
molecules. EFNs are divided into A and B subfamilies.
EFNAs are GPI-anchored cell surface proteins and
EFNBs are transmembrane cell surface proteins. Ephs
and EFNs interact promiscuously. EphA members
mainly interact with EFNA members, while EphB mem-
bers mainly interact with EFNB members. When Ephs
and EFNs interact, signals are transmitted in both direc-
tions, i.e., from Ephs to EFNs and from EFNs to Ephs.
Such bi-directional signalling is called forward and
reversed signalling respectively [1].
EFNB1 is involved in the development and function of
the central nervous system [2]. It is also essential in
bone maintenance and remodelling [3]. EFNB1 expres-
sion in platelets contributes to the clotting process [4].
Its expression on kidney epithelial cells (podocytes)
likely plays a role in glomerular filtration [5]. EFNB1 is
involved in intestinal epithelial cell homeostasis [6]. We
have shown that EFNB1 forward signalling through their
Eph receptors can costimulate peripheral T cells in
terms of enhancing cytokine production and prolifera-
tion in vitro and enhance thymocyte survival [7,8]. To
further understand the role of EFNB1 in T cell develop-
ment and function, we generated T-cell-specific gene
knockout mice. The effects of EFNB1 on their immune
system are presented here.
Methods
Generation of T cell-specific EFNB1 gene knockout mice
T cell-specific EFNB1 gene knockout mice were gener-
ated in our laboratory as described [9]. First, EFNB1
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exon 1 was flanked with loxP sites. These floxed mice
were backcrossed to the C57BL/6 background for more
than nine generations and then mated with Lck-promo-
ter-driven Cre transgenic (Tg) mice in the C57BL/6
background {strain B6.Cg-Tg(Lck-cre)I540Jxm/J, Jackson
Laboratory, Bar Harbor, Maine, USA} to obtain T cell-
specific EFNB1 gene knockout mice. Since EFNB1 is an
X-linked gene, the deletion of an EFNB1 gene in one
allele in males equals the deletion of the gene in two
alleles in females. These mice were collectively called
EFNB1f/f/cre mice for convenience, regardless of gender.
Floxed males or females without the Cre transgene were
used as controls and were collectively called EFNB1f/f
mice.
All mice were housed under specific pathogen-free
conditions and used in accordance with a protocol
approved by the Institutional Animal Protection Com-
mittee of the University of Montreal Hospital Center
(NO9055JWs).
Immunofluorescent microscopy
One hundred thousand thymocytes in single cell suspen-
sion were applied to glass slides using Statspin® cyto-
fuge (IRIS international INC., Westwood, MA, USA) at
850 RPM for 4 min. Cells were fixed with 4% parafor-
maldehyde for 15 min and then blocked with PBS con-
taining 10% FBS. Cells were then stained with 4 μg/ml
goat anti-EFNB1 Ab (Clone 94038, R&D systems, Min-
neapolis, MN, USA) overnight at 4°C, followed by 0.25
μg/ml PE-donkey anti-goat IgG Ab (Jackson ImmunoRe-
search Laboratories, Inc., West Grove, PA, USA) for 45
min. The slides were mounted with prolong® Gold anti-
fade reagent (Invitrogen, Eugene, OR) and examined
under a Carl Zeiss microscope using AxioVision™ soft-
ware (Jena, Germany).
Flow Cytometry
Single cell suspensions from the thymus and spleen
were prepared and stained for flow cytometry as
described in our previous publications (Yu et al., 2004;
Yu et al., 2006). For intracellular antigen staining, cells
were first stained with Abs against cell surface antigens
fixed with Cytofix/Cytoperm solution (BD Biosciences,
San Diego, CA, USA), then stained with Ab against
intracellular antigens. Next, Abs were used for flow
cytometry as follows: anti-mouse CD4 PerCP (0.2 μg/μl,
Clone no. RM4-5); anti-mouse CD8 APC (0.2 μg/μl,
Clone no. 53-6.7); anti-mouse CD25 APC (0.2 μg/μl,
Clone no. 7D4); anti-mouse CD69 FITC (0.2 μg/μl,
Clone no. H1.2F3); anti-mouse Thy1.2 PE (0.2 μg/μl,
Clone no. 53-2.1); anti-mouse B220 APC-Cy™ 7 (0.2
μg/μl, Clone no. RA3-6B2); anti-mouse CD3 APC (clone
no. 2C11); anti-mouse CD62L PE (clone no. MEL-14);
anti-mouse CD45.1 FITC (clone no.A20); anti-mouse
CD45.2 PerCP (clone no.104); anti-mouse IFN-g FITC
(0.2 μg/μl, Clone no. B27); anti-mouse IL4 PE (0.2 μg/
μl, Clone no. BVD4-1D11); anti-mouse IL17 PE (0.2 μg/
μl, Clone no. TC11-18H10) (BD Bioscience Pharmingen,
San Diego, CA, USA); anti-mouse CD44 Pacific bue
(clone no. 1M7, BioLegend, San Diego, CA); and anti-
mouse FoxP3 APC (0.2 μg/μl, Clone no. FJK-16s)
(eBioscience, San Diego, CA, USA).
T cell activation and proliferation assay
Total spleen cells were stimulated with soluble hamster
anti-mouse CD3 mAb (100 ng/ml, clone 2C11) plus rat
anti-mouse CD28 mAb (1 μg/ml, clone no. 37.51.1).
After 16 h culture, cells were stained with PE-rat anti-
mouse Thy1.2 (clone no.53-21) and FITC-rat anti-CD25
(clone no.7D4) or anti-CD69 mAb (clone H1.2F3), and
analyzed with 2-color flow cytometry. For T cell prolif-
eration, spleen T cells were purified using Easysep®
Mouse T cell enrichment kit (Stemcell technologies,
Vancouver, BC, Canada) and cultured in wells coated
with hamster anti-mouse CD3 mAb (1 μg/ml for coat-
ing) alone or hamster anti-mouse CD3 mAb (0.1 μg/ml
for coating) plus rat anti-mouse CD28 (1 μg/ml for
coating). 3H-thymidine uptake of the cultured cells was
measured at 24 h, 48 h and 72 h after culture, as
described in our previous publication [7].
Generation of bone marrow chimeras
Eight to 10-week-old C57BL/6 (CD45.2+) × C57/B6.SJL
(CD45.1+) F1 mice were irradiated at 1,100 Rads.
Twenty-four hours later, they received 4x106 T cell-
depleted bone marrow cells from. Efnb1f//f/cre alone or
C57/B6.SJL and Efnb1f//f/cre mice in a 1:1 ratio. Efnb1f//f
mouse bone marrow was used as a control. Spleen cells
of the recipients were analyzed by flow cytometry 8 to
10 weeks following the bone marrow transplantation
(BMTx).
In vitro Th1, Th2, Th17 and Treg polarization
Th1, Th2, Th17 and Treg populations were polarized
from naïve CD4+ T cells that were isolated from pooled
splenocytes and lymph node cells using Naïve CD4+ T
Cells Isolation Kits (R&D Systems). Purity of the naïve
CD4+ cells was routinely greater than 95%. Purified
naïve T cells (0.1 × 106/well) were mixed with T cell-
depleted irradiated (3000 Rads) C57BL/6 feeder spleno-
cytes (0.5 × 106 cells/well), and cultured in 96-well
plates in RPMI medium 1640 containing 10% FCS, 100
μg/ml streptomycin, 100 units/ml penicillin G, 1× non-
essential amino acids, 1 μM sodium pyruvate, 2.5 μM b-
mercaptoethanol, and 2 μg/ml soluble hamster anti-
CD3ε mAb (clone 145-2C11; 2 μg/ml). For Th1 polari-
zation, rmIL-12 (10 ng/ml) and rat anti-IL-4 mAb (10
μg/ml, clone 11B11) were added to the culture. For Th2
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polarization, rmIL-4 (20 ng/ml), rat anti-IL-12 mAb
(Clone no.48110 10 μg/ml,) and rat anti-IFN-g mAb (10
μg/ml, Clone no 37895) were added. For Th17 polariza-
tion, cultures were supplemented with recombinant
mouse IL-6 (20 ng/ml), recombinant human TGF-b1 (5
ng/ml), and rat anti-IL-4 mAb and rat-anti-IFN-gmAb
(10 μg/ml). For Treg polarization, recombinant human
TGF-b1 (5 ng/ml) and rat anti-IL-4 and rat anti-IFN-
gmAb (both at 10 μg/ml) were added to the culture.
Recombinant cytokines and mAb against cytokines were
all from R & D Systems (Minneapolis, MN, USA). Five
days after culture, 5 nM of PMA, 500 ng/ml of ionomy-
cin, and protein transport inhibitor BD GolgiStop™ (BD
Bioscience; San Diego, CA, USA) were added for the
last four hours of culture. Cells were harvested and
stained for intracellular cytokines or FoxP3 followed by
flow cytometry analysis.
Results
EFNB1 deletion in T cells
To confirm the deletion of EFNB1 in the T cell com-
partment, we conducted an immunofluorescence study
on thymocytes using Thy1.2 and EFNB1 double staining.
Control Thy1.2+ thymocytes (in green) expressed EFNB1
(in red) (Figure 1A, upper row), while EFNB1 was not
detectable in Thy1.2+ thymocytes from EFNB1f/f/cre mice
(Figure 1A, bottom row). The deletion of EFNB1 was
confirmed in mature spleen T cells by flow cytometry
analysis (Figure 1B). These results demonstrated that
EFNB1 was indeed deleted in the T-linage cells in KO
mice.
Cellularity and cell subpopulations in the thymus and
spleen of EFNB1f/f/cre mice
There was no gross morphological difference between
EFNB1f/f/cre and EFNB1f/f thymi. They were of similar
weight and cellularity, as shown in Figures 2. Thymo-
cytes from EFNB1f/f/cre mice were analyzed by flow cyto-
metry for different cell populations. Representative
histograms are shown in Figure 2B, and 2bar graphs in
Figure 2C summarize the results of 13 independent
experiments. EFNB1f/f/cre and EFNB1f/f mice had com-
parable percentages of CD4CD8 double positive (DP),
CD4 single positive (SP), and CD8 SP thymocytes. Con-
versely, there was a moderate but significant increase in
CD4CD8 double negative (DN) thymocytes in EFNB1f/f/
cre mice compared to EFNB1f/f mice. Further analysis of
DN thymocytes revealed that the augmented percentage
of DN was due to the heightened percentage of DN3
stage cells in EFNB1f/f/cre mice (Figure 2D).
The spleen weight and cellularity of EFNB1f/f/cre mice
showed no significant difference compared to controls
(Figures 3A &3B) after analyzing 13 pairs of mice. Dif-
ferent spleen cell populations were assessed by flow
cytometry. Histograms from representative experiments
are shown in Figures 3C and 3D, and a summary of
results from 13 independent experiments are illustrated
as bar graphs in Figure 3E. T and B cell populations in
the EFNB1f/f/cre spleens were comparable to those of
EFNB1f/f spleens (Figures 3C &3F). No apparent differ-
ence was found in the ratios of CD4 and CD8 cells
between KO and control spleens (Figures 3D &3F). We
next examined whether there is any change of naive ver-
sus memory population in EFNB1 KO T cell. As shown
in 3E, no difference was observed in the percentage of
CD44loCD62Lhi EFNB1f/f/cre naïve CD4 T cells and
CD44hiCD62Llo EFNB1 KO memory CD4 T cells com-
pared with the littermate control CD4 T cells in the
spleen.
To determine the requirement for EFNB1 in early T
cell development and T cell proliferation, we intrave-
neously transferred bone marrow hematopoietic pro-
genitors from EFNB1f/f/cre or EFNB1f/f mice into lethally
irradiated B6.SJL CD45.1 × C57BL/6 CD45.2 F1 hosts.
In those single chimeras, the donor contribution
(CD45.2 single positive) was about 90%. T-cell depleted
bone marrow cells from EFNB1f/f/cre or EFNB1f/f gener-
ated similar sized pool of peripheral T cells (Figure 4A).
We further examined T cell production of EFNB1f/f/cre
or EFNB1f/f bone marrow progenitors in competitive
repopulation experiment. To this end, we used a model
of whole body irradiation (WBI) followed by bone mar-
row transplantation (BMTx), using B6.SJL bone marrow
cells to compete with EFNB1f/f/cre or EFNB1f/f bone
marrow cells. In this model, CD45.1 single positive cells
were derived from competitor B6.SJL bone marrow
cells; CD45.2 single positive cells were derived from
EFNB1f/f/cre or EFNB1f/f bone marrow cells; and
CD45.1/CD45.2 double positive cells were derived from
residual recipient bone marrow cells and peripheral
cells. As shown in Figure 4B, there was similar amount
of the spleen cells derived from donor bone marrow
cells (CD45.2 single positive cells) and competitor B6.
SJL bone marrow cells (CD45.1 single positive cells) no
matter whether the donor bone marrow cells derived
from EFNB1f/f/cre or EFNB1f/f mice. While gated on
CD45.2 single positive cells, no significant differences
were found in the repopulated spleen T cells of the reci-
pients received bone marrow cells from mixture of
EFNB1f/f/cre and B6.SJL mice compared with that of the
recipients received bone marrow cells from mixture of
control EFNB1f/f and B6.SJL mice. This indicates that
the EFNB1f/f/cre bone marrow cells were comparable to
the EFNB1f/f control bone marrow cells in their capacity
to compete with B6.SJL bone marrow cells to develop
and expand in the void niche created by irradiation.
Taken together, the results show that T cell develop-
ment was minimally affected in the absence of EFNB1.
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In vitro activation and proliferation of EFNB1f/f/cre T cells
were not compromised
Next, we investigated the function of peripheral EFNB1f/
f/cre T cells in terms of activation and proliferation.
Spleen T cells were purified by negative selection using
magnetic beads; the purified cells contained more than
95% CD3 positive cells. They were cultured in wells
coated with anti-CD3 and anti-CD28. After overnight
culture, they were analyzed for the expression of activa-
tion markers such as CD25 and CD69. More than 95%
Figure 1 T cell-specific deletion of EFNB1 in Lck-EFNB1f/f mice according to immunofluorescent microscopy and flow cytometry. A.
Thymocytes from EFNB1f/f (upper row) or Lck-EFNB1f/f (bottom row) mice were stained with FITC-rat anti-Thy1.2 (green) and PE-rat anti-EFNB1
(red) mAbs. Micrographs of the cells with pseudocolouring are shown. B. CD3-gated spleen T cells from EFNB1f/f/cre mice or EFNB1f/f controls
were analyzed for EFNB1 expression by flow cytometry. The dotted line represents isotypic control Ab, and solid line, anti-EFNB1 Abs. Percentage
of EFNB1 positive cells was indicated. The experiments were repeated three times and data from representative ones are shown.
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Figure 2 Phenotype of Lck-EFNB1f/f thymi. A. Thymus size and cellularity of Lck-EFNB1f/f mice. N = 13 pairs (p > 0.05; paired Student’s t test). B
and C. Subpopulations of thymocytes from Lck-EFNB1f/f and EFNB1f/f mice according to flow cytometry. Representative histograms are shown in B
and bar graphs summarize data from 13 independent experiments are illustrated in C (p > 0.05; paired Student’s t test). D. The percentages of
DN1, DN2, DN3 and DN4 cells in Lck-EFNB1f/f and EFNB1f/f mice from 9 independent experiments are shown in bar graphs (paired Student’s t
test).
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Figure 3 Phenotype of Lck-EFNB1f/f spleens. A and B. Spleen size and cellularity of Lck-EFNB1f/f and EFNB1f/f mice. N = 13 pairs (p> 0.05; paired
Student’s t test). C, D and E. Spleen T cell, B cell, CD4 T cell, CD8 T cell, CD4 naive cell and CD4 momery cell population of Lck-EFNB1f/f mice
according to flow cytometry. Representative histograms are shown in C and D, and bar graphs summarize data from 13 independent experiments
are illustrated in F (p > 0.05; paired Student’s t test).
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Figure 4 Lck-EFNB1f/f progenitors reconstitute the spleen in irradiated recipients. A. 2 ×106 T-cell depleted bone marrow cells from Lck-
Cre-EFNB1f/f (top panel) or control EFNB1f/f mice (bottom panel) were transferred to lethally irradiated C57BL/6 × SJL F1 recipients, followed by
analysis 8 to 10 weeks later. Percentage of CD45.2+ cells (derived from Lck-Cre-EFNB1f/f or EFNB1f/f bone marrow cells), and CD45.1+/CD45.2+
cells (derived from residue cells of the recipients) is indicated. B. 1 × 106 T-cell depleted Lck-Cre-EFNB1f/f and EFNB1f/f bone marrow cells (CD45.2
+) were mixed with T-cell depleted bone marrow cells from B6.SJL competitor at 1:1 ratio, and transplanted to lethally irradiated C57BL/6 × SJL
F1 recipients. After 8 to 10 weeks, cells from spleen were analyzed for CD45.2 and CD45.1 staining. Percentage of CD45.2+ cells (derived from
Lck-Cre-EFNB1f/f or EFNB1f/f bone marrow cells), CD45.1+ cells (derived from competing B6.SJL bone marrow cells), and CD45.1+/CD45.2+ cells
(derived from residue cells of the recipients) is indicated. In the WBI-BMTx models as described in Figure 4A and B, B220+ B cells and CD3+ T
cells among CD45.2+ cells (derived from Lck-Cre-EFNB1f/f or EFNB1f/f bone marrow cells) in the spleen were determined by flow cytometry, and
their percentage is shown.
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of the T cells from EFNB1f/f/cre mice upregulated their
CD25 and CD69 expression within 16 h; such upregula-
tion was comparable to that of T cells from EFNB1f/f
mice (Figure 5A). Meanwhile, no significant change of
EFNB1 expression was noted between resting and acti-
vated T cells from EFNB1f/f mice (Figure 5B).
We then examined proliferation of T cells from
EFNB1f/f/cre mice. Purified spleen T cells were cultured
in wells coated with anti-CD3 mAb (1 μg/ml for coat-
ing), or anti-CD3 plus anti-CD28 mAb (0.1 μg/ml and 1
μg/ml for coating, respectively); and their proliferation
was determined at 24, 48 and 72 h according to3H-thy-
midine uptake. A summary of three independent experi-
ments is illustrated in Figures 4B and 4C. Overall,
EFNB1f/f/cre T cells showed no compromise in their abil-
ity to proliferate upon solid phase anti-CD3 mAb (Fig-
ure 5C) or anti-CD3 plus anti-CD28 mAb (Figure 5D)
stimulation. Of importance, anti-CD3 Ab concentration
(1 μg/ml) was higher in wells coated with anti-CD3 Ab
alone, compared to the concentration used in wells
coated with anti-CD3 plus anti-CD28 Abs. This shows
that the maximal proliferation under these two condi-
tions was similar.
In vitro differentiation of EFNB1f/f/Cre T cells
Since EFNB1f/f/Cre T cells showed no abnormality in
activation and proliferation, we next assessed whether
they could properly differentiate into different functional
subpopulations. Spleen naive CD4 T cells from EFNB1f/
f/Cre and control EFNB1f/f mice were cultured under
conditions favouring the development of Th1 (Figure
6A), Th2 (Figure 6B), Th17 (Figure 6C) and Treg (Fig-
ure 6D) cells. After optimal durations of culture for
each type of cell, the cells were collected and analyzed
for their intracellular IFN-g, IL4, IL17 and FoxP3 con-
tent by flow cytometry. After differentiation, as shown
in Figures 6A-6D, EFNB1f/f/Cre and EFNB1f/f CD4 cells
were comparable in their percentage of intracellular
IFN-g+, IL4+, IL17+ and FoxP3+ cells. This indicates that
EFNB1f/f/Cre CD4 cells are capable of normal differentia-
tion into Th1, Th2, Th17 and Treg cells.
Discussion
We investigated T cell development in mice with T cell-
specific deletion of EFNB1. Results show that in the
absence of EFNB1, the thymus and spleen showed mostly
normal subpopulations of T cell origin. In single chi-
meras and competitive chimaeras, the EFNB1f/f/cre bone
marrow cells demonstrated comparable T cell develop-
ment as the control EFNB1f/f bone marrow cells. More-
over, mature T cells had no apparent defects in their
activation and proliferation or in their ability to differ-
entiate into functional Th1, Th2, Th17 and Treg cells.
Previous in vitro studies using foetal thymus organ
culture have shown that recombinant EFNB1 protein is
capable of influencing T cell development and enhan-
cing thymocyte survival [8]. In another study [7], solid
phase EFNB1 was shown to increase mature T cell
response to TCR stimulation. How do we reconcile
these observations with the present findings that EFNB1
deletion showed no apparent impact on T cell develop-
ment and mature T cell function? As mentioned in the
introduction, EFNB1 promiscuously interacts with mul-
tiple EphB family members such as EphB1, B2, B3, B4,
and B6, as well as with a few EphA family members
such as EphA4 and EphA3. When soluble EFNB1 is
introduced into thymus organ culture, it not only blocks
the interaction of multiple Ephs with EFNB1, but also
likely interferes with interactions between those Ephs
and other EFN members. When EFNB1 is placed on
solid phase, it will noticeably trigger signalling of multi-
ple Ephs. Such effects cannot be achieved by simple
EFNB1 deletion. In the absence of EFNB1, its forward
signalling to other Eph molecules and its reverse signal-
ling are likely compensated by other EFNs.
The absence of a demonstrated phenotype in T cell
development and function following EFNB1 deletion
does not prove that this molecule is unimportant. On
the contrary, this observation suggests an essential
importance of EFNB1. It can be argued that the role of
EFNB1 in the T cell compartment is so essential, that
any accidental mutation could lead to disastrous conse-
quences. As a counter measure to prevent such disasters
from occurring, through evolution, we have developed
highly redundant Eph and EFN systems, as well as pro-
miscuous interactions between Eph and EFN members.
With such a system, any aberrant mutation that occurs
to certain Eph or EFN members will be safely compen-
sated by others in such a way as to guarantee their nor-
mal function in the T cell compartment. It is further
inferred that the true importance of EFNs can only be
revealed if a deletion of multiple EFN family members
occurs at the same time. Through our studies on T cell-
specific deletion of both EFNB1 and EFNB2 in mice
[9]), we found that in the absence of both EFNB1 and
EFNB2, there was compromised abT cell development
in the thymus along with abnormal thymic structure.
The EFNB1/EFNB2 KO T cells significantly failed to
compete with normal T cells during homeostatic expan-
sion in irradiated recipients. EFNB1/EFNB2 double KO
T cells were significantly inferior to normal T cells in
their ability to differentiate into Th1 and Th17 cells.
Such a handicap resulted in compromised in vivo T
cell-mediated immune responses such as allograft rejec-
tion and anti-virus immunity. These results confirm the
critical role of EFNB1 in T cell development and
Jin et al. BMC Immunology 2011, 12:68
http://www.biomedcentral.com/1471-2172/12/68
Page 8 of 10
Figure 5 Normal activation and proliferation of Lck-EFNB1f/f T cells. A. Activation marker expression. Total spleen cells from Lck-EFNB1f/f and
EFNB1f/f mice were stimulated with soluble anti-CD3 mAb and anti-CD28 mAbs for 48 hours, and stained with PE-rat anti-mouse Thy1.2 and
FITC-rat anti-mouse CD25 or CD69, followed by flow cytometry analysis. B. EFNB1 expression in activated T cells. Total spleen cells from EFNB1 f/f
mice were cultured in medium or with anti-CD3 mAb for 48 hours, and stained with Thy1.2 -FITC and PE-rat anti-EFNB1 mAbs. The percentage
of EFNB1 positive cells gated on T cells is indicated. C and D. T cell proliferation. Purified T cells from Lck-EFNB1f/f and EFNB1f/f mice were cultured
in wells coated with solid phase anti-CD3 (C) or anti-CD3 plus anti-CD28 mAb (D) for 24 to 72 h. The cells were pulsed with3 H-thymidine for
the last 16 h of the culture. Samples were in triplicate. Mean ± SD of cpm are shown. Experiments were repeated more than 5 times and
representative data are shown.
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function. However, this role was not observed in the
EFNB1 single KO mice used in this study.
Conclusions
To conclude, we are the first to have carried out an ana-
lysis of roles of T cell development and function in the
mice with conditional EFNB1 deletion in the T cell
compartment, though the effect of the single EFNB1 KO
appears to be minimal. Our results suggest that the
function of EFNB1 in the T cell compartment could be
compensated by other members of the EFN family, and
that such redundancy safeguards the pivotal roles of
EFNB in T cell immunity. Additional studies on EFNB
family, i.e. EFNB1, EFNB2 and EFNB3, double or even
triple null mutated mice to investigate T cell develop-
ment and function are warranted to confirm such
indications.
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Figure 6 CD4 cell in vitro differentiation. Naïve CD4 cells were cultured under conditions favouring Th1 (A), Th2 (B), Th17 (C) and Treg (D)
cells. Their intracellular cytokine or FoxP3 expression was determined by flow cytometry. Experiments were repeated more than 5 times and
representative data are shown.
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